Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:17964783rdf:typepubmed:Citationlld:pubmed
pubmed-article:17964783lifeskim:mentionsumls-concept:C0206529lld:lifeskim
pubmed-article:17964783lifeskim:mentionsumls-concept:C0220781lld:lifeskim
pubmed-article:17964783lifeskim:mentionsumls-concept:C1883254lld:lifeskim
pubmed-article:17964783lifeskim:mentionsumls-concept:C0243076lld:lifeskim
pubmed-article:17964783lifeskim:mentionsumls-concept:C1880022lld:lifeskim
pubmed-article:17964783lifeskim:mentionsumls-concept:C0243072lld:lifeskim
pubmed-article:17964783pubmed:issue24lld:pubmed
pubmed-article:17964783pubmed:dateCreated2007-11-16lld:pubmed
pubmed-article:17964783pubmed:abstractTextA series of 1,3-dihydrobenzo[b][1,4]diazepin-2-one derivatives was evaluated as non-competitive mGluR2/3 antagonists. Attachment of an 8-(2-aryl)-ethynyl-moiety produced compounds inhibiting the binding of [(3)H]-LY354740 to rat mGluR2 with low nanomolar affinity and consistent functional effect at both mGluR2 and mGluR3.lld:pubmed
pubmed-article:17964783pubmed:languageenglld:pubmed
pubmed-article:17964783pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17964783pubmed:citationSubsetIMlld:pubmed
pubmed-article:17964783pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17964783pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17964783pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17964783pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17964783pubmed:statusMEDLINElld:pubmed
pubmed-article:17964783pubmed:monthDeclld:pubmed
pubmed-article:17964783pubmed:issn1464-3405lld:pubmed
pubmed-article:17964783pubmed:authorpubmed-author:AlanineAlexan...lld:pubmed
pubmed-article:17964783pubmed:authorpubmed-author:GattiSilviaSlld:pubmed
pubmed-article:17964783pubmed:authorpubmed-author:AdamGeoGlld:pubmed
pubmed-article:17964783pubmed:authorpubmed-author:MutelVincentVlld:pubmed
pubmed-article:17964783pubmed:authorpubmed-author:KnoflachFrédé...lld:pubmed
pubmed-article:17964783pubmed:authorpubmed-author:WichmannJürge...lld:pubmed
pubmed-article:17964783pubmed:authorpubmed-author:WolteringThom...lld:pubmed
pubmed-article:17964783pubmed:issnTypeElectroniclld:pubmed
pubmed-article:17964783pubmed:day15lld:pubmed
pubmed-article:17964783pubmed:volume17lld:pubmed
pubmed-article:17964783pubmed:ownerNLMlld:pubmed
pubmed-article:17964783pubmed:authorsCompleteYlld:pubmed
pubmed-article:17964783pubmed:pagination6811-5lld:pubmed
pubmed-article:17964783pubmed:meshHeadingpubmed-meshheading:17964783...lld:pubmed
pubmed-article:17964783pubmed:meshHeadingpubmed-meshheading:17964783...lld:pubmed
pubmed-article:17964783pubmed:meshHeadingpubmed-meshheading:17964783...lld:pubmed
pubmed-article:17964783pubmed:meshHeadingpubmed-meshheading:17964783...lld:pubmed
pubmed-article:17964783pubmed:meshHeadingpubmed-meshheading:17964783...lld:pubmed
pubmed-article:17964783pubmed:meshHeadingpubmed-meshheading:17964783...lld:pubmed
pubmed-article:17964783pubmed:meshHeadingpubmed-meshheading:17964783...lld:pubmed
pubmed-article:17964783pubmed:meshHeadingpubmed-meshheading:17964783...lld:pubmed
pubmed-article:17964783pubmed:year2007lld:pubmed
pubmed-article:17964783pubmed:articleTitleSynthesis and characterization of 8-ethynyl-1,3-dihydro-benzo[b][1,4]diazepin-2-one derivatives: new potent non-competitive metabotropic glutamate receptor 2/3 antagonists. Part 1.lld:pubmed
pubmed-article:17964783pubmed:affiliationF. Hoffmann-La Roche Ltd, Pharma Discovery Chemistry, CNS CH-4070 Basel, Switzerland.lld:pubmed
pubmed-article:17964783pubmed:publicationTypeJournal Articlelld:pubmed
http://linkedlifedata.com/r...http://linkedlifedata.com/r...pubmed-article:17964783lld:chembl